DexCom
DXCM
DXCM
310 hedge funds and large institutions have $7.14B invested in DexCom in 2017 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 146 increasing their positions, 87 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 44
97% less call options, than puts
Call options by funds: $14.8M | Put options by funds: $509M
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
310
Holding in Top 10
–
Calls
$14.8M
Puts
$509M
Top Buyers
| 1 | +$499M | |
| 2 | +$117M | |
| 3 | +$71.6M | |
| 4 |
Bank of New York Mellon
New York
|
+$50.9M |
| 5 |
FAM
Fred Alger Management
New York
|
+$50.9M |
Top Sellers
| 1 | -$109M | |
| 2 | -$94.9M | |
| 3 | -$75M | |
| 4 |
CCI
Columbus Circle Investors
|
-$67.8M |
| 5 |
BM
Bridger Management
New York
|
-$32.6M |